Company News Press Release ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025 cnhnewcorpdev October 17, 2025
Company News Press Release ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test cnhnewcorpdev September 25, 2025
Company News Press Release ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test cnhnewcorpdev July 9, 2025
Company News Press Release ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients cnhnewcorpdev June 16, 2025
Company News Press Release ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025 cnhnewcorpdev April 23, 2025
Company News Press Release ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks cnhnewcorpdev March 12, 2025
Company News Press Release ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health cnhnewcorpdev February 18, 2025
Company News Press Release ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study cnhnewcorpdev January 7, 2025
